| __timestamp | CRISPR Therapeutics AG | Travere Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 1513000 | 47795223 |
| Thursday, January 1, 2015 | 12573000 | 50426000 |
| Friday, January 1, 2016 | 42238000 | 70853000 |
| Sunday, January 1, 2017 | 69800000 | 78168000 |
| Monday, January 1, 2018 | 113773000 | 123757000 |
| Tuesday, January 1, 2019 | 179362000 | 140963000 |
| Wednesday, January 1, 2020 | 266946000 | 131773000 |
| Friday, January 1, 2021 | 438633000 | 210328000 |
| Saturday, January 1, 2022 | 461645000 | 235780000 |
| Sunday, January 1, 2023 | 387332000 | 244990000 |
| Monday, January 1, 2024 | 320653000 |
Unlocking the unknown
In the rapidly evolving world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, CRISPR Therapeutics AG and Travere Therapeutics, Inc. have demonstrated contrasting trajectories in their R&D investments. Starting in 2014, CRISPR Therapeutics AG's R&D expenses skyrocketed by over 25,000%, peaking in 2022 with a 30% increase from the previous year. Meanwhile, Travere Therapeutics, Inc. showed a steady growth of approximately 400% in the same period, with a notable 16% rise in 2023. This divergence highlights CRISPR's aggressive push in gene-editing technologies, while Travere maintains a consistent focus on rare diseases. As we look to the future, these spending patterns may well dictate the pace of breakthroughs and market leadership in the biotech sector.
Who Prioritizes Innovation? R&D Spending Compared for Vertex Pharmaceuticals Incorporated and CRISPR Therapeutics AG
Research and Development Investment: Regeneron Pharmaceuticals, Inc. vs CRISPR Therapeutics AG
R&D Insights: How Neurocrine Biosciences, Inc. and CRISPR Therapeutics AG Allocate Funds
Research and Development: Comparing Key Metrics for Jazz Pharmaceuticals plc and Travere Therapeutics, Inc.
Analyzing R&D Budgets: Verona Pharma plc vs Travere Therapeutics, Inc.
Research and Development Investment: Ultragenyx Pharmaceutical Inc. vs CRISPR Therapeutics AG
Viking Therapeutics, Inc. or CRISPR Therapeutics AG: Who Invests More in Innovation?
Comparing Innovation Spending: CRISPR Therapeutics AG and Veracyte, Inc.
Analyzing R&D Budgets: CRISPR Therapeutics AG vs Geron Corporation
Analyzing R&D Budgets: CRISPR Therapeutics AG vs Iovance Biotherapeutics, Inc.
Research and Development: Comparing Key Metrics for Protagonist Therapeutics, Inc. and Travere Therapeutics, Inc.
Analyzing R&D Budgets: Travere Therapeutics, Inc. vs Xencor, Inc.